Prognostic Factors for Survival in Adult Patients With Grade II Glial Tumors

Basit Öğe Kaydı
dc.authorid0000-0003-2333-353Xen_US
dc.authorid0000-0002-0447-7784en_US
dc.contributor.authorÖnder, Hatice
dc.contributor.authorKanyılmaz, Gül
dc.contributor.authorMeryem , Aktan
dc.contributor.authorKarahacıoğlu, Eray
dc.date.accessioned2020-01-18T21:02:50Z
dc.date.available2020-01-18T21:02:50Z
dc.date.issued2018
dc.departmentNEÜ, Meram Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Bölümü, Anabilim Dalıen_US
dc.description.abstractAim: To investigate survival results of patients with low grade gliomas (LGGs) and to evaluate the predictive role of clinico-pathologic prognostic factors on survival.Material and Methods: Between 2003 and 2014, the adult patients with Grade II glial tumors were evaluated retrospectively. Several variables were investigated to find prognostic factors related with the overall survival (OS) and progression-free survival (PFS).Results: This study involved in 124 patients with median 40 months follow up. The average OS for the all patients was 7.8 years. 2-, 5- and 10- year OS ratios were 91%, 73% and 55%, respectively. Patients with low pignatti risk score had a longer OS than high pignatti risk score (p0.01). Patients with seizure had a better OS (p0.03). Patients with biopsy/partial resection had a poorer OS (p0.02). Patients with residue after initial surgery had a worse OS (p0.03). If the patients had recurrence or progression, the patients had poorer OS (p0.01). Tumor with malignant transformation (p0.01) and glioblastoma subtype after second surgery (p0.003) had a poorer OS. The Pignatti risk score and seizure were the independent prognostic factors for PFS.Conclusion: The extent of surgery and recurrence or progression of Grade II glioma were the independent prognostic factors for OS. The Pignatti risk score and seizure were the independent prognostic factors for PFS.en_US
dc.identifier.citationÖnder, H., Kanyılmaz, G., Aktan, M., Karahacıoğlu, E. (2018). Prognostic factors for survival in adult patients with grade II glial tumors. Journal of Turgut Ozal Medical Center, 25, 1, 105-111.en_US
dc.identifier.endpage111en_US
dc.identifier.issn1300-1744en_US
dc.identifier.issue1en_US
dc.identifier.startpage105en_US
dc.identifier.urihttp://app.trdizin.gov.tr/publication/paper/detail/TWpjME9ETXlNZz09
dc.identifier.urihttps://hdl.handle.net/20.500.12452/1308
dc.identifier.volume25en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofTurgut Özal Tıp Merkezi Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US]
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGenel ve Dahili Tıpen_US
dc.subjectGrade II Gliomaen_US
dc.subjectPrognostic Factorsen_US
dc.subjectProgression Or Recurrence Free Survivalen_US
dc.subjectRadiotherapyen_US
dc.subjectSurvivalen_US
dc.titlePrognostic Factors for Survival in Adult Patients With Grade II Glial Tumorsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
hatice önder.pdf
Boyut:
329.75 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text/Tam Metin
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu